Busulfan–Melphalan followed by autologous stem cell transplantation in patients with high-risk neuroblastoma or Ewing sarcoma: an exposed–unexposed study evaluating the clinical impact of the order of drug administration
Crossref DOI link: https://doi.org/10.1038/bmt.2016.109
Published Online: 2016-04-25
Published Print: 2016-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Dourthe, M E
Ternès, N
Gajda, D
Paci, A
Dufour, C
Benhamou, E
Valteau-Couanet, D
Text and Data Mining valid from 2016-04-25
Version of Record valid from 2016-04-25
Article History
First Online: 25 April 2016
Competing interests
: The authors declare no conflict of interest.